Agilent Technologies EPS - Earnings per Share 2012-2025 | A
Agilent Technologies annual and quarterly earnings per share history from 2012 to 2025. Earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.
- Agilent Technologies EPS for the quarter ending October 31, 2025 was $1.53, a 24.39% increase year-over-year.
- Agilent Technologies EPS for the twelve months ending October 31, 2025 was $4.57, a 3.16% increase year-over-year.
- Agilent Technologies 2025 annual EPS was $4.57, a 3.16% increase from 2024.
- Agilent Technologies 2024 annual EPS was $4.43, a 5.73% increase from 2023.
- Agilent Technologies 2023 annual EPS was $4.19, a 0.24% increase from 2022.
| Agilent Technologies Annual EPS | |
|---|---|
| 2025 | $4.57 |
| 2024 | $4.43 |
| 2023 | $4.19 |
| 2022 | $4.18 |
| 2021 | $3.94 |
| 2020 | $2.30 |
| 2019 | $3.37 |
| 2018 | $0.97 |
| 2017 | $2.10 |
| 2016 | $1.40 |
| 2015 | $1.20 |
| 2014 | $1.62 |
| 2013 | $2.13 |
| 2012 | $3.27 |
| 2011 | $2.85 |
| Agilent Technologies Quarterly EPS | |
|---|---|
| 2025-10-31 | $1.53 |
| 2025-07-31 | $1.18 |
| 2025-04-30 | $0.75 |
| 2025-01-31 | $1.11 |
| 2024-10-31 | $1.23 |
| 2024-07-31 | $0.97 |
| 2024-04-30 | $1.05 |
| 2024-01-31 | $1.18 |
| 2023-10-31 | $1.60 |
| 2023-07-31 | $0.38 |
| 2023-04-30 | $1.02 |
| 2023-01-31 | $1.19 |
| 2022-10-31 | $1.24 |
| 2022-07-31 | $1.10 |
| 2022-04-30 | $0.91 |
| 2022-01-31 | $0.93 |
| 2021-10-31 | $1.45 |
| 2021-07-31 | $0.86 |
| 2021-04-30 | $0.70 |
| 2021-01-31 | $0.93 |
| 2020-10-31 | $0.71 |
| 2020-07-31 | $0.64 |
| 2020-04-30 | $0.32 |
| 2020-01-31 | $0.63 |
| 2019-10-31 | $0.63 |
| 2019-07-31 | $0.60 |
| 2019-04-30 | $0.57 |
| 2019-01-31 | $1.57 |
| 2018-10-31 | $0.60 |
| 2018-07-31 | $0.73 |
| 2018-04-30 | $0.63 |
| 2018-01-31 | $-0.99 |
| 2017-10-31 | $0.54 |
| 2017-07-31 | $0.54 |
| 2017-04-30 | $0.50 |
| 2017-01-31 | $0.52 |
| 2016-10-31 | $0.38 |
| 2016-07-31 | $0.38 |
| 2016-04-30 | $0.28 |
| 2016-01-31 | $0.36 |
| 2015-10-31 | $0.42 |
| 2015-07-31 | $0.33 |
| 2015-04-30 | $0.26 |
| 2015-01-31 | $0.19 |
| 2014-10-31 | $0.05 |
| 2014-07-31 | $0.43 |
| 2014-04-30 | $0.41 |
| 2014-01-31 | $0.58 |
| 2013-10-31 | $0.63 |
| 2013-07-31 | $0.49 |
| 2013-04-30 | $0.48 |
| 2013-01-31 | $0.51 |
| 2012-10-31 | $1.21 |
| 2012-07-31 | $0.69 |
| 2012-04-30 | $0.72 |
| 2012-01-31 | $0.65 |
| 2011-10-31 | $0.83 |
| 2011-07-31 | $0.92 |
| 2011-04-30 | $0.56 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $36.458B | $6.948B |
| Agilent Technologies, Inc. is an original equipment manufacturer of a broad-based portfolio of test and measurement products serving multiple end markets. Recently, the company has diversified into new end markets, namely industrial, chemical and electronics markets. The company has three business segments, including Life Sciences & Applied Markets Group (LSAG), Diagnostics and Genomics Group (DGG) and Agilent Cross Lab Group (ACG).The company uses a direct sales model for the distribution of its products, which is supplemented by distributors, resellers, manufacturers' representatives, telesales and electronic commerce, as necessary. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $197.518B | 22.06 |
| EssilorLuxottica (ESLOY) | France | $154.739B | 0.00 |
| Stryker (SYK) | United States | $139.087B | 26.68 |
| Medtronic (MDT) | Ireland | $129.586B | 17.95 |
| Boston Scientific (BSX) | United States | $108.915B | 24.09 |
| Medline (MDLN) | United States | $59.170B | 0.00 |
| Lonza Group Ag (LZAGY) | Switzerland | $46.091B | 0.00 |
| ResMed (RMD) | United States | $37.821B | 25.25 |
| GE HealthCare Technologies (GEHC) | United States | $36.095B | 17.29 |
| Koninklijke Philips (PHG) | Netherlands | $30.881B | 18.33 |
| Terumo (TRUMY) | Japan | $20.046B | 22.65 |
| Zimmer Biomet Holdings (ZBH) | United States | $18.948B | 11.66 |
| Insulet (PODD) | United States | $17.647B | 54.77 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $14.998B | 0.00 |
| Baxter (BAX) | United States | $11.448B | 9.24 |
| Sunny Optical Technology (SNPTF) | China | $8.485B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $7.922B | 28.49 |
| Demant (WILYY) | Denmark | $6.264B | 0.00 |
| Envista Holdings (NVST) | United States | $4.976B | 25.22 |
| Lantheus Holdings (LNTH) | United States | $4.461B | 13.59 |
| BillionToOne (BLLN) | United States | $3.924B | 0.00 |
| ICU Medical (ICUI) | United States | $3.647B | 23.16 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.263B | 0.00 |
| Prestige Consumer Healthcare (PBH) | United States | $3.122B | 14.73 |
| Haemonetics (HAE) | United States | $2.672B | 11.69 |
| Neogen (NEOG) | United States | $2.338B | 51.19 |
| Phibro Animal Health (PAHC) | United States | $2.088B | 18.40 |
| Perrigo (PRGO) | Ireland | $2.009B | 5.03 |
| LeMaitre Vascular (LMAT) | United States | $1.991B | 40.08 |
| QuidelOrtho (QDEL) | United States | $1.956B | 13.59 |
| Curaleaf Holdings (CURLF) | Canada | $1.649B | 0.00 |
| AtriCure (ATRC) | United States | $1.635B | 0.00 |
| Kestra Medical Technologies (KMTS) | United States | $1.625B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.427B | 20.67 |
| Green Thumb Industries (GTBIF) | United States | $1.390B | 60.91 |
| Lumexa Imaging Holdings (LMRI) | United States | $1.304B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $1.106B | 0.00 |
| BioLife Solutions (BLFS) | United States | $1.071B | 317.86 |
| InMode (INMD) | Israel | $0.902B | 9.89 |
| Tilray Brands (TLRY) | Canada | $0.888B | 0.00 |
| Valneva SE (VALN) | France | $0.834B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.798B | 0.00 |
| Omeros (OMER) | United States | $0.796B | 0.00 |
| CeriBell (CBLL) | United States | $0.763B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.570B | 13.61 |
| Brainsway (BWAY) | Israel | $0.459B | 78.10 |
| Verano Holdings (VRNO) | United States | $0.432B | 0.00 |
| Cerus (CERS) | United States | $0.413B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.394B | 0.00 |
| SNDL (SNDL) | Canada | $0.386B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.361B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.328B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.321B | 25.61 |
| Quanterix (QTRX) | United States | $0.279B | 0.00 |
| Evolus (EOLS) | United States | $0.279B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.240B | 0.00 |
| Owens & Minor (OMI) | United States | $0.217B | 2.17 |
| Sanuwave Health (SNWV) | United States | $0.212B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.206B | 18.45 |
| High Tide (HITI) | Canada | $0.205B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.202B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.195B | 57.33 |
| TerrAscend (TSNDF) | Canada | $0.188B | 0.00 |
| Accendra Health (ACH) | United States | $0.184B | 1.85 |
| Organigram Global (OGI) | Canada | $0.177B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.176B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.174B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.157B | 0.00 |
| Apyx Medical (APYX) | United States | $0.150B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.133B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.129B | 0.00 |
| Fonar (FONR) | United States | $0.115B | 16.74 |
| MacroGenics (MGNX) | United States | $0.109B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.098B | 0.00 |
| Biote (BTMD) | United States | $0.097B | 4.24 |
| Exagen (XGN) | United States | $0.075B | 0.00 |
| ImmuCell (ICCC) | United States | $0.059B | 24.96 |
| Sharps Technology (STSS) | United States | $0.048B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.043B | 0.00 |
| Nephros (NEPH) | United States | $0.043B | 31.08 |
| Cytosorbents (CTSO) | United States | $0.039B | 0.00 |
| Veru (VERU) | United States | $0.037B | 0.00 |
| Modular Medical (MODD) | United States | $0.035B | 0.00 |
| United-Guardian (UG) | United States | $0.030B | 15.40 |
| Jin Medical (ZJYL) | China | $0.025B | 0.00 |
| Bonk (BNKK) | United States | $0.020B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.014B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.014B | 0.00 |
| Flora Growth (FLGC) | United States | $0.009B | 0.00 |
| INLIF (INLF) | China | $0.009B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.007B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.006B | 0.00 |
| Zynex (ZYXI) | United States | $0.004B | 0.00 |
| Functional Brands (MEHA) | United States | $0.004B | 0.00 |
| Agape ATP (ATPC) | $0.003B | 0.00 | |
| Meihua Medical Technologies (MHUA) | China | $0.002B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.002B | 0.00 |
| InterCure (INCR) | Israel | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.000B | 0.00 |